Skip to content
Medical Health Aged Care

Australia’s leading training college welcomes new specialist GPs in the Northern Territory

Royal Australian College of GPs 3 mins read

The Royal Australian College of GPs (RACGP) has welcomed new fellows as specialist GPs at a fellowship ceremony in Darwin.

They shared the spotlight with an RACGP award recipient, Dr Hang Murphy, who has gone above and beyond for her patients in Alice Springs. Fellowship of the RACGP (FRACGP) reflects a doctor’s qualification and expertise as a specialist GP, following around 11 years of education, training, rigorous assessment, and experience in primary care. Multiple surveys show nine in 10 participants in the Australian General Practice Training program (AGPT), which is funded by the Federal Government, are satisfied with the quality of overall training. 

RACGP President, Dr Nicole Higgins, congratulated the new fellows.

“Boosting the GP workforce must be a priority. As the peak GP body responsible for training 90% of GPs across Australia, including the Northern Territory, we’re working harder than ever to ensure all communities have access to quality care from a GP they know and trust,” she said.

“Following the ceremony at Parliament House in Darwin, our new GPs are ready to care for people in communities in the Territory. There is no substitute for the quality care provided by a GP who knows you and your history. So, it’s vital governments and regulators do everything possible to back us to succeed and let us focus on what we do best – caring for our patients. We keep people healthy and out of hospital beds. I congratulate our new fellows and wish them all the best in their careers helping patients from all walks of life.”

RACGP Northern Territory Chair, Dr Sam Heard, joined Dr Higgins in welcoming the new specialist GPs.

“These new GPs will make such a vital difference. They will provide invaluable care to patients, in cities like Darwin and Alice Springs, and also regional and remote parts of the Territory,” he said.

“I can tell you from personal experience, that being a GP is such a rewarding job. Ask any GP in the Territory or across Australia, and they will tell you that every day is a new opportunity to help people in your community. People not only know who you are but value the work you do immensely. I’m glad to report that the RACGP is achieving great success bringing GPs in training to rural and remote areas where they are needed most, and this will help to boost our non-urban GP workforce in the Territory.”

The fellowship ceremony also celebrated the achievements of the Territory’s RACGP GP of the Year Dr Hang Murphy. Based in Alice Springs, Dr Murphy has worked tirelessly for many years in Aboriginal health at her practice, going that extra mile to improve the health and wellbeing of her patients. Despite being the only full-time GP at her practice, Dr Murphy attends many workshops and courses so that she can provide the most up-to-date healthcare possible.

Dr Hang also supervises students and is involved in a variety of research projects, with a special interest in household hygiene to prevent skin sores which can lead to rheumatic heart disease – a significant problem in her community.

Other attendees included the Northern Territory Health Minister the Hon Steven Edgington MLA, the CEO of Northern Territory Health Mr Chris Hosking, Director of the Northern Territory Medical Program at Flinders University Associate Professor Emma Kennedy, Foundation Dean at Charles Darwin University Medical Program Professor Dianne Stephens, Northern Territory Chief Health Officer Adjunct Professor Christine Connors, and CEO of the Northern Territory Primary Health Network Ms Gill Yearsley.

~ENDS        


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

Media

More from this category

  • Medical Health Aged Care
  • 16/01/2025
  • 08:41
Mainstay Medical Holdings plc

Mainstay Medical Announces Positive Outcomes from Landmark RESTORE Clinical Trial of ReActiv8®

ReActiv8® Restorative NeurostimulationTM demonstrated statistically significant and clinically meaningful superiority vs. standard of care in all primary and secondary measures of disability, pain and…

  • Contains:
  • Medical Health Aged Care
  • 16/01/2025
  • 06:05
Royal Australian College of GPs

ADHD reform more urgent in NSW with psychiatrists’ workforce crisis

The Royal Australian College of GPs is urging the New South Wales Government to prioritise reforms to improve access to support and treatment for people with attention deficit hyperactivity disorder (ADHD) from GPs after the mass resignation of psychiatrists. Around 200 psychiatrists in NSW's public health system have submitted their resignations amid an ongoing pay dispute with the state government. RACGP New South Wales Chair Dr Rebekah Hoffman said: “GPs should be able to initiate and prescribe medications for people living with ADHD, and manage their care. Allowing GPs to give more support to people living with ADHD will improve…

  • Medical Health Aged Care
  • 16/01/2025
  • 05:00
GlaxoSmithKline

Local scientific discovery Omjarra (momelotinib) now TGA approved for Australians with rare bone marrow cancer

Embargoed: 06.00am Thursday 16th January 2025, MELBOURNE, AUSTRALIA Omjjara (momelotinib) was discovered by Melbourne scientists in 2005.1 Today’s TGA approval follows its recent FDA approval and makes it one of only a handful of original Australian scientific discoveries to secure both milestones.1-6 Omjjara is a once daily pill indicated to treat disease-related consequences of primary or secondary myelofibrosis including spleen enlargement and moderate to severe anaemia.7 Myelofibrosis is a rare bone marrow cancer with an average survival of 5-7 years.7-8 GSK Australia welcomes the Therapeutic Goods Administration (TGA) approval of Omjjara - a local scientific discovery now providing the first…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.